A Comparison of the Diagnostic Confidence and Image Quality Between the Eyoto Theia (RDSL) and a Predicate Device.

NCT ID: NCT05783583

Last Updated: 2023-04-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

49 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-10-01

Study Completion Date

2023-01-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A clinical study has been identified as a requirement for the RDSL (Theia). This study involves a clinical comparison of the imaging from the RDSL with that of a predicate device.

The clinical evaluation showed that there remains some residual risk in the practitioner's ability to use the imaging from the RDSL to detect pathologies at the same level as when using the imaging function on a predicate device.

The aim of this comparative study is to determine the degree, if any, of difference in using images captured from the RDSL for clinical inspection of pathologies, when compared to images captured from a predicate device.

Due to the involvement of real patients during the study, ethics approval was sought prior to commencement. This study is limited to the clinical benefits of the device.

An additional Human factors study has been conducted to assess the useability of the device Images were taken of healthy eyes and eyes with pathology (with images of several pathologies from each major pathology group to give a full range) on both the predicate device, and the RDSL.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Methodology

Overview Images were taken of 14 healthy eyes and 35 unhealthy eyes containing a range of pathologies on both the predicate device and the THEIA. The pathologies to be imaged have been carefully selected using data from the clinical evaluation, and further investigation, to ensure that all aspects of the imaging systems and ocular structures are included.

The images were taken on compliant patients in a real-world setting.

Device Selection Device Type:AC-powered remote enabled slit-lamp Manufacturer:Eyoto Product Number:THEIA (3-008-0001-03)

Intended Use:

The THEIA is intended for non-invasive examination, illumination, magnification, visualization and recording of digital photographs and video of the anterior and posterior eye segments of the human eye and its surrounding area.

Magnification:6 (base Magnification), 10X, 16X, 25X (digital steps) Filters:Blue filter,Red-free filter (digital filter),yellow Filter (fluorescein enhancement filter) Lighting:White LED,12 V, 0.7 - 1.5 A, 8.4 W Image Sensor,CMOS, 1.1", 12 Megapixel The latest pre-production version of the THEIA was used. This is representative of and has all the same functionality as, the production model.

Three individual THEIA devices of the same version were used to collect the images.

Predicate Device Device Type:AC-powered slit lamp biomicroscope Manufacturer:Topcon Product Number:Topcon SL-2G or equivalent (SL-2D with imaging attachment) Intended Use:The Slit Lamp SL-2G is an AC-powered slit lamp biomicroscope intended for use in eye examination of the anterior eye segment, from the cornea epithelium to the posterior capsule. It is used to aid in the diagnosis of diseases or trauma which affect the structural properties of the anterior eye segment.

Magnification:10X, 16X, 25X Filters:Blue filter, Red-free filter, Yellow Filter (fluorescein enhancement filter) available as an accessory Lighting:White LED Image Sensor (DC-4):CMOS, 5 Megapixel

The predicate device used for this study was equivalent to the Topcon SL-2G used in the substantial equivalence investigation, used with the recommended Topcon Digital Imaging Adaptor (DC-4) in order to take the images required.

Three individual predicate devices will be used to collect the images.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cataract

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Enrolled participants

Adult human subjects showing either healthy eyes or specific ocular pathologies.

Remote Digital Slit Lamp

Intervention Type DEVICE

Slit Lamp Examination

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Remote Digital Slit Lamp

Slit Lamp Examination

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy eye or ocular pathology

Exclusion Criteria

* No exclusion other than age as above
Minimum Eligible Age

21 Years

Maximum Eligible Age

99 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Eyoto Group Ltd

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

John Bankowski, DOO

Role: PRINCIPAL_INVESTIGATOR

National Vision Inc

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

National Vision Inc Corporate Office

Atlanta, Georgia, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EYO-CS-001.1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Adaptive Optics Retinal Imaging
NCT02317328 RECRUITING
Peripheral Retina Robotically Aligned OCT Study
NCT06451068 NOT_YET_RECRUITING NA
Retinal Imaging Using NOTAL-OCT
NCT03374020 COMPLETED
Camera Qualification Study
NCT05808699 ACTIVE_NOT_RECRUITING